Patent: 9,763,918
✉ Email this page to a colleague
Summary for Patent: 9,763,918
Title: | Compositions and methods for treating chronic urticaria |
Abstract: | Disclosed herein are methods of treating conditions, which may be associated with elevated levels of mast cells, basophils, eosinophils, or a combination thereof, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof. |
Inventor(s): | Bozik; Michael E. (Pittsburgh, PA), Dworetzky; Steven (Jefferson Hills, PA) |
Assignee: | Knopp Biosciences LLC (Pittsburgh, PA) |
Application Number: | 14/912,015 |
Patent Claims: | see list of patent claims |
Details for Patent 9,763,918
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2033-08-13 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2033-08-13 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2033-08-13 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2033-08-13 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 02/01/2007 | ⤷ Try a Trial | 2033-08-13 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |